Capital International Investors Adaptive Biotechnologies Corp Transaction History

Capital International Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $21.2 Million - $60.5 Million	-2,093,732 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $3.88 Million - $5.15 Million	129,116 Added 6.57%	2,093,732 $71.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $4.25 Million - $5.88 Million	131,812 Added 7.19%	1,964,616 $80.3 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $2.6 Million - $4.73 Million	69,852 Added 3.96%	1,832,804 $73.8 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $1.54 Million - $2.24 Million	34,202 Added 1.98%	1,762,952 $104 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $3.82 Million - $5.22 Million	106,846 Added 6.59%	1,728,750 $84.1 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $2.49 Million - $4.83 Million	99,800 Added 6.56%	1,621,904 $78.5 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $15.6 Million - $31.5 Million	922,104 Added 153.68%	1,522,104 $42.3 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $24.2 Million - $29 Million	600,000 New	600,000 $29 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $631M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.